Publications

 

 

  1. Shashanka Sarkar, Mansi Sharma, Arpita Karmakar, Kousar Jahan, Sheetanshu Saproo, Soumojit Biswas, Sakshi Nautiyal, Ipsita Roy, Bharatam P.V., Srivatsava Naidu*. NSH76: A Selective Inhibitor of RRN3 and RNA Polymerase I Transcription with Potential for Cancer therapy. J. Transl. Med. (Accepted)
  2. A. Shakya, R. Saharan, C. Gupta, R. Kumar, L. Sharma, S. Naidu, S. Murala, C. Arora. Two-Stage, Global-Local Approach for Cell Nuclei Segmentation in Histopathology Images, 2024 IEEE 8th International Conference on Information and Communication Technology (CICT), Prayagraj UP, India, 2024, pp. 1-6, doi: 10.1109/CICT64037.2024.10899523.
  3. Sarkar, S.S., Sharma, M., Saproo, S., Naidu S*. LINC01116-dependent upregulation of RNA polymerase I transcription drives oncogenic phenotypes in lung adenocarcinoma. J. Transl. Med. 22, 904 (2024). https://doi.org/10.1186/s12967-024-05715-5
  4. Anggi Muhtar Pratama, Mansi Sharma, Srivatsava Naidu, Heike Bommel, Samudyata C. Prabhuswamimath, Madhusudhan Thati, Hevi Wihadmadyatami, Akash Bachhuka, Srikanth Karnati. Peroxisomes and PPARs: Emerging role as master regulators of cancer metabolism. Molecular Metabolism, 102044 (2024), https://doi.org/10.1016/j.molmet.2024.102044.
  5. Kamble, P., Nagar, P.R., Bhakhar, K.A., Garg, P., Sobhia, ME., Naidu, S and Bharatam, PV. Cancer pharmacoinformatics: Databases and analytical tools. Funct Integr Genomics 24, 166 (2024). https://doi.org/10.1007/s10142-024-01445-5
  6. Sheetal Yadav, Srivatsava Naidu, Bodhisatwa Das. In vitro systems to demonstrate the nano effect (scope: In vitro systems to demonstrate the efficacy and safety of biomaterials for nanomedicine applications). Nanomedicine in Translational Research, 41-61, ISBN 9780443222573, (2024), https://doi.org/10.1016/B978-0-443-22257-3.00003-9.
  7. Indira Kundu†, Shivani Varshney†, Srikanth Karnati, Srivatsava Naidu*. The Multifaceted Roles of Circular RNAs in Cancer Hallmarks: From Mechanisms to Clinical Implications. Molecular Therapy – Nucleic Acids, Volume 35, Issue 3. 2024, 102286, https://doi.org/10.1016/j.omtn.2024.102286.
  8. Srivatsava Naidu*, Srikanth Karnati, Harikrishnan Radhakrishnan, Anand Gupta. EDITORIAL: Role of non-coding RNAs (Emphasis on the Emerging Role of Circular RNAs) In Cancer. Application Potential for Molecular Diagnostics and Therapeutics of Cancer. 2024, (Invited Editorial). Frontiers in Genetics – RNA. VOLUME 15, 2024, DOI-10.3389/fgene.2024.1450309
  9. Chatterjee S, Chowdhury A, Saproo S, Mani Tripathi N, Naidu S, Bandyopadhyay A. Capturing Sialyl-glycan on Live Cancer Cells by Tailored Boronopeptide. Chemistry. 2023 Dec 5:e202303327. doi: 10.1002/chem.202303327. Epub ahead of print. PMID: 38051420.
  10. Sourav Chattopadhyay, Shashanka S Sarkar, Sheetanshu Saproo, Sheetal Yadav, Deepika Antil, Bodhisatwa Das and Srivatsava Naidu*. Apoptosis-targeted gene therapy for non-small cell lung cancer using Poly-lactic-coglycolic acid -based nano-delivery system and CASP8 and miRs 29A-B1 and 34A. Front. Bioeng. Biotechnol. – Preclinical Cell and Gene Therapy. 11 – 2023. doi.org/10.3389/fbioe.2023.1188652.
  11. Sheetanshu Saproo, Shashanka S. Sarkar, Vishakha Gautam, Chingmei W. Konyak, Gouri Dass, Arpita Karmakar, Mansi Sharma, Gaurav Ahuja, Anand Gupta, Juhi Tayal, Anurag Mehta and Srivatsava Naidu*. Salivary protein kinase C alpha and novel microRNAs as diagnostic and therapeutic resistance markers for oral squamous cell carcinoma in Indian cohorts (2022). Front. Mol. Biosci. doi: 10.3389/fmolb.2022.1106963.
  12. Vivek Singh Rana, Vivek Anand, Shashanka Shekhar Sarkar, Navjot Sandhu, Meenakshi Verma, Srivatsava Naidu, Kamlesh Kumar, Rajesh K. Yadav, Rahul Shrivastava, Atul P. Singh. A novel pyrene-based aggregation induced enhanced emission active Schiff base fluorophore as a selective “turn-on” sensor for Sn2+ ions and its application in lung adenocarcinoma cells. Journal of Photochemistry and Photobiology A: Chemistry, 436,2023,114409.
  13. Sheetanshu Saproo, Shashanka S. Sarkar, Ekta Gupta, Sourav Chattopadhyay, Aarzoo Charaya, Siddhant Kalra, Gaurav Ahuja, Srivatsava Naidu*. MiR-330-5p and miR-1270 target essential components of RNA polymerase I transcription and exhibit a novel tumor suppressor role in lung adenocarcinoma (Oct 2022). Cancer Gene Ther. doi: 10.1038/s41417-022-00544-4.
  14. Mittal A, Mohanty SK, Gautam V, Arora S, Saproo S, Gupta R, Sivakumar R, Garg P, Aggarwal A, Raghavachary P, Dixit NK, Singh VP, Mehta A, Tayal J, Naidu S, Sengupta D, Ahuja G. Artificial intelligence uncovers carcinogenic human metabolites. Nat Chem Biol. 2022 Aug 11. doi: 10.1038/s41589-022-01110-7.
  15. Vishakha Gautam, Aayushi Mittal, Siddhant Kalra, Sanjay Kumar Mohanty, Krishan Gupta, Komal Rani, Srivatsava Naidu, Tripti Mishra, Debarka Sengupta, Gaurav Ahuja. EcTracker: Tracking and elucidating ectopic expression leveraging large-scale scRNA-seq studies. Briefings in Bioinformatics, 22, Issue 6, November 2021.
  16. Siddhant Kalra, Aayushi Mittal, Krishan Gupta, Vrinda Singhal, Anku Gupta, Tripti Mishra, Srivatsava Naidu, Debarka Sengupta & Gaurav Ahuja. Analysis of single-cell transcriptomes links enrichment of olfactory receptors with cancer cell differentiation status and prognosis. Communications Biology, 2020, Vol 3, 506.
  17. S. Nema, A. Dudhane, S. Murala, S. Naidu. RescueNet: An unpaired GAN for brain tumor segmentation. Biomedical Signal Processing and Control, Vol 55, 2020, 101641.
  18. Sandhu, S. Saproo, S. Naidu, A. P. Singh, K. Kumar, A. P. Singh, R. K. Yadav.”Turn‐On” Sensing Behaviour of an In Situ Generated Fluorescein‐Based Probe and Its Preferential Selectivity of Sodium Hypochlorite over tert‐Butyl Hydroperoxide in Lung Adenocarcinoma Cells. Chemistry Select 2020, 5, 1264.
  19. Srivatsava Naidu, Shi L, Magee P, Middleton JD, Laganá A, Sahoo S, Leong HS, Galvin M, Frese K, Dive C, Guzzardo V, Fassan M and Garofalo M. (2017) PDGFR-modulated miR-23b cluster and miR-125a-5p suppress lung tumorigenesis by targeting multiple components of KRAS and NF-kB pathways. Sci Rep. 2017 Nov 13;7(1):15441. doi: 10.1038/s41598-017-14843-6.
  20. Srivatsava Naidu and Michela Garofalo. MicroRNAs: an emerging paradigm in lung cancer chemoresistance. Front Med. 2015 Nov 4;2:77.
  21. Cristian Taccioli, M. Garofalo, H. Chen, Y. Jiang, G. M. Tagliazucchi, G. di Leva, H. Alder, P. Fadda, J. Middleton, K. J.Smalley, T. Selmi, S. Naidu, J. L. Farber, C. M. Croce, L. Y. Fong. (2015). Anti-miR-31 Delivery In Vivo Represses Esophageal Neoplasia and Inflammatory Signaling. J Natl Cancer Inst. 2015 Aug 18;107(11). pii: djv220. doi: 10.1093/jnci/djv220.
  22. Srivatsava Naidu., Peter Magee and Michela Garofalo. (2015). miRNA-based therapeutic intervention of cancer. J. Hematol. Oncol. 2015 Jun 11;8(1):68. doi: 10.1186/s13045-015-0162-0.
  23. Srivatsava Naidu, Lei Shi and Michela Garofalo. (2015). MicroRNAs in lung tumorigenesis and chemoresistance. Am Assoc Cancer Res Educ Book. 2015:71-74
  24. Srivatsava Naidu*, J. Karsten Friedrich*, Jackie Russell and Joost Zomerdijk. (2011). TAF1B is a TFIIB-like component of the basal transcription machinery for RNA polymerase I. Science. 333: 1640 – 1642. * equal contribution, (Rated as top 2% by F1000)
  25. Vijayan, V., Baumgart, E.V., S. Naidu, G.Qian and S. Immenschuh. (2011). Bruton’s Tyrosine kinase is required for TLR-dependent heme oxygenase – 1 gene activation via Nrf2 in macrophages. J. Immunol. 187: 817 – 827.
  26. Naidu, S., V. Vijayan, S. Santoso, T. Kietzmann and S. Immenschuh. (2009). Inhibition and genetic deficiency of p38 MAPK up-regulates heme oxygenase-1 gene expression via NF-E2-related factor-2 (Nrf2). J. Immunol. 182: 7048–7057.
  27. Immenschuh, S., S. Naidu, T. Chavakis, H. Beschmann, R. J. Ludwig and S. Santoso. (2009). Transcriptional induction of Junction adhesion molecule-C gene expression in activated T cells. J. leuk. Biol. 85: 796-803.
  28. Naidu, S., N. Wijayanti, S. Santoso, T. Kietzmann and S. Immenschuh. (2008). An atypical NF-kappa B-regulated pathway mediates phorbol ester-dependent heme oxygenase-1 gene activation in monocytes. J. Immunol.181: 4113-4123.
  29. Wijayanti, N., S. Naidu, T. Kietzmann, and S. Immenschuh. (2008). Inhibition of phorbol ester-dependent peroxiredoxin I gene activation by lipopolysaccharide via phosphorylation of RelA/p65 at serine 276 in monocytes. Free. Radic. Biol. Med.44: 699-710.

 

 

 

Patents

 

 

  1. Sourav Chattopadhyay and Srivatsava Naidu. METHOD OF SYNTHESIS OF CELLULOSE 2,3 DIAMINO HALAMINE (Granted – 22/5/2023, Patent number: 432385).
  2. Sourav Chattopadhyay and Srivatsava Naidu. METHOD OF SYNTHESIS OF CHITOSAN BASED N-HALAMINE (Granted – 21/09/2023, Patent number: 453541)
  3. 3. Sourav Chattopadhyay and Srivatsava Naidu – Max Specialty films limited: Synthesis and validation of germicidal coating for BOPP films (Joint Patent – commercial: Filed, application number, 202111017949)